Princeton Alpha Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-20,541
| Closed | -$107K | – | 321 |
|
|
2017
Q1 | $107K | Sell |
20,541
-15,585
| -43% | -$81.2K | 0.04% | 513 |
|
|
2016
Q4 | $110K | Buy |
36,126
+14,885
| +70% | +$45.3K | 0.02% | 650 |
|
|
2016
Q3 | $98K | Sell |
21,241
-7,087
| -25% | -$32.7K | 0.02% | 707 |
|
|
2016
Q2 | $164K | Buy |
+28,328
| New | +$164K | 0.03% | 692 |
|
|
2016
Q1 | – | Sell |
-16,895
| Closed | -$154K | – | 897 |
|
|
2015
Q4 | $154K | Buy |
+16,895
| New | +$154K | 0.03% | 665 |
|
|
2015
Q3 | – | Sell |
-12,850
| Closed | -$143K | – | 881 |
|
|
2015
Q2 | $143K | Buy |
+12,850
| New | +$143K | 0.03% | 638 |
|
|
2015
Q1 | – | Sell |
-10,809
| Closed | -$164K | – | 868 |
|
|
2014
Q4 | $164K | Buy |
+10,809
| New | +$164K | 0.05% | 599 |
|